Scopolamine Patch, Extended Release
FDA Label NDC 70771-1787

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Scopolamine (NDC 70771-1787). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Scopolamine transdermal system, 1 mg/3 days

Carton of 4 transdermal systems

NDC 70771-1787-4

Rx only

4's Carton (Bcf83e45 2959 4bb5 Aebf Bcf69a10beb7 01)

4's Carton (Bcf83e45 2959 4bb5 Aebf Bcf69a10beb7 01)

* Please review the disclaimer below.